{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T10:40:03Z","timestamp":1745577603329,"version":"3.40.4"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,3,26]],"date-time":"2025-03-26T00:00:00Z","timestamp":1742947200000},"content-version":"vor","delay-in-days":25,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Capital's Funds for Health Improvement and Research","award":["2022-1-2152, 2022-4-2156 and 2024-1-2151"],"award-info":[{"award-number":["2022-1-2152, 2022-4-2156 and 2024-1-2151"]}]},{"name":"National Key Research and Development Program of Chin","award":["2023YFF0613403"],"award-info":[{"award-number":["2023YFF0613403"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82070205, 81972807, 81670187, 32300655 and 82300214"],"award-info":[{"award-number":["82070205, 81972807, 81670187, 32300655 and 82300214"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Beijing Natural Science Foundation","award":["L244063 and L244025","L244063"],"award-info":[{"award-number":["L244063 and L244025","L244063"]}]},{"name":"Cultivation plan in Haidian District","award":["HP2022-19-503004"],"award-info":[{"award-number":["HP2022-19-503004"]}]},{"name":"Beijing Hospital Authority Cultivation plan","award":["PX2022046"],"award-info":[{"award-number":["PX2022046"]}]},{"name":"Beijing Research Ward Excellence Program","award":["BRWEP2024W032150205"],"award-info":[{"award-number":["BRWEP2024W032150205"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1007\/s00277-025-06314-0","type":"journal-article","created":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T08:07:29Z","timestamp":1743235649000},"page":"1705-1712","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Low levels of CD3\u2009+\u2009and CD8\u2009+\u2009T cells in peripheral blood can predict poor efficacy of first-line chemotherapy in patients with angioimmunoblastic T cell lymphoma"],"prefix":"10.1007","volume":"104","author":[{"given":"Yanfei","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiwei","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqin","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,26]]},"reference":[{"issue":"1","key":"6314_CR1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/annonc\/mdf033","volume":"13","author":"T R\u00fcdiger","year":"2002","unstructured":"R\u00fcdiger T, Weisenburger DD, Anderson JR, Armitage JO, Diebold J, MacLennan KA et al (2002) Peripheral T-cell lymphoma (excluding anaplastic large-cell lymphoma): results from the non-Hodgkin\u2019s lymphoma classification project. Ann Oncol 13(1):140\u2013149. https:\/\/doi.org\/10.1093\/annonc\/mdf033PubMed PMID: WOS:000174060900035","journal-title":"Ann Oncol"},{"issue":"25","key":"6314_CR2","doi-asserted-by":"publisher","first-page":"4124","DOI":"10.1200\/Jco.2008.16.4558","volume":"26","author":"JM Vose","year":"2008","unstructured":"Vose JM, Neumann M, Harris ME, Project IT-CL (2008) International peripheral T-cell and natural killer\/T-cell lymphoma study: pathology findings and clinical outcomes. J Clin Oncol 26(25):4124\u20134130. https:\/\/doi.org\/10.1200\/Jco.2008.16.4558PubMed PMID: WOS:000259350200011","journal-title":"J Clin Oncol"},{"issue":"7","key":"6314_CR3","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1038\/s41375-022-01620-2","volume":"36","author":"R Alaggio","year":"2022","unstructured":"Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBD, Berti E et al (2022) The 5th edition of the world health organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia 36(7):1720\u20131748. https:\/\/doi.org\/10.1038\/s41375-022-01620-2PubMed PMID: WOS:000814462100003","journal-title":"Leukemia"},{"key":"6314_CR4","doi-asserted-by":"crossref","unstructured":"Lunning MA, Vose JM (2017) Angioimmunoblastic T-cell lymphoma: the many-faced lymphoma. Blood.;129(9):1095\u2013\u2009102. doi: 10.1182\/blood-2016-09-692541. PubMed PMID: WOS:000397142500010","DOI":"10.1182\/blood-2016-09-692541"},{"issue":"3","key":"6314_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1182\/blood.2020010387","volume":"138","author":"RH Advani","year":"2021","unstructured":"Advani RH, Skrypets T, Civallero M, Spinner MA, Manni M, Kim WS et al (2021) Outcomes and prognostic factors in angioimmunoblastic T-cell lymphoma: final report from the international T-cell project. Blood 138(3):213\u2013220 doi: 10.1182\/blood.2020010387. PubMed PMID: WOS:000677493800005","journal-title":"Blood"},{"issue":"5","key":"6314_CR6","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1080\/10428194.2021.2015586","volume":"63","author":"C Zhang","year":"2022","unstructured":"Zhang C, Mi L, Wu M, Liu WP, Ma HM, Ren JX et al (2022) Angioimmunoblastic T-cell lymphoma: treatment strategies and prognostic factors from a retrospective multicenter study in China. Leuk Lymphoma 63(5):1152\u20131159 PubMed PMID: WOS:000734811300001","journal-title":"Leuk Lymphoma"},{"issue":"4","key":"6314_CR7","doi-asserted-by":"publisher","first-page":"3987","DOI":"10.1002\/cam4.5248","volume":"12","author":"C Wei","year":"2023","unstructured":"Wei C, Li W, Qin LP, Liu S, Xue C, Ren KX et al (2023) Clinicopathologic characteristics, outcomes, and prognostic factors of angioimmunoblastic T-cell lymphoma in China. Cancer Med-Us 12(4):3987\u20133998. https:\/\/doi.org\/10.1002\/cam4.5248PubMed PMID: WOS:000853783700001","journal-title":"Cancer Med-Us"},{"key":"6314_CR8","doi-asserted-by":"publisher","unstructured":"Kusano Y, Yokoyama M, Terui Y, Nishimura N, Mishima Y, Ueda K et al (2017) Low absolute peripheral blood CD4\u2009+\u2009T-cell count predicts poor prognosis in R-CHOP-treated patients with diffuse large B-cell lymphoma (7, e558, 2017). Blood Cancer J 7:ARTN e561 https:\/\/doi.org\/10.1038\/bcj.2017.43. PubMed PMID: WOS:000402205200001","DOI":"10.1038\/bcj.2017.43"},{"issue":"10","key":"6314_CR9","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1007\/s00262-017-2026-7","volume":"66","author":"S Battella","year":"2017","unstructured":"Battella S, Cox MC, La Scaleia R, Di Napoli A, Di Landro F, Porzia A et al (2017) Peripheral blood T cell alterations in newly diagnosed diffuse large B cell lymphoma patients and their long-term dynamics upon rituximab-based chemoimmunotherapy. Cancer Immunol Immun 66(10):1295\u20131306. https:\/\/doi.org\/10.1007\/s00262-017-2026-7PubMed PMID: WOS:000412228500005","journal-title":"Cancer Immunol Immun"},{"issue":"10","key":"6314_CR10","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.3109\/10428194.2010.503820","volume":"51","author":"AP Gonzalez-Rodriguez","year":"2010","unstructured":"Gonzalez-Rodriguez AP, Contesti J, Huergo-Zapico L, Lopez-Soto A, Fern\u00e1ndez-Guiz\u00e1n A, Acebes-Huerta A et al (2010) Prognostic significance of CD8 and CD4 T cells in chronic lymphocytic leukemia. Leuk Lymphoma 51(10):1829\u20131836 PubMed PMID: WOS:000282895200012","journal-title":"Leuk Lymphoma"},{"issue":"1","key":"6314_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s11060-022-04032-5","volume":"159","author":"A Berthelot","year":"2022","unstructured":"Berthelot A, Bequet C, Harlay V, Petrirena G, Campello C, Barri\u00e9 M et al (2022) Prognostic value of Circulating lymphocyte subsets in primary central nervous system lymphoma. J Neuro-Oncol 159(1):15\u201322 PubMed PMID: WOS:000817817100002","journal-title":"J Neuro-Oncol"},{"issue":"1","key":"6314_CR12","doi-asserted-by":"publisher","first-page":"101","DOI":"10.2174\/1871520615666150824153523","volume":"16","author":"SM Cand\u00e9ias","year":"2016","unstructured":"Cand\u00e9ias SM, Gaipl US (2016) The immune system in cancer prevention, development and therapy. Anti-Cancer Agent Me 16(1):101\u2013107. https:\/\/doi.org\/10.2174\/1871520615666150824153523PubMed PMID: WOS:000365043100010","journal-title":"Anti-Cancer Agent Me"},{"issue":"8","key":"6314_CR13","doi-asserted-by":"publisher","first-page":"1482","DOI":"10.1093\/annonc\/mdw168","volume":"27","author":"JM Pitt","year":"2016","unstructured":"Pitt JM, Marabelle A, Eggermont A, Soria JC, Kroemer G, Zitvogel L (2016) Targeting the tumor microenvironment: removing obstruction to anticancer immune responses and immunotherapy. Ann Oncol 27(8):1482\u20131492. https:\/\/doi.org\/10.1093\/annonc\/mdw168PubMed PMID: WOS:000383182800016","journal-title":"Ann Oncol"},{"issue":"6","key":"6314_CR14","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1016\/j.cell.2018.07.009","volume":"174","author":"KK Dijkstra","year":"2018","unstructured":"Dijkstra KK, Cattaneo CM, Weeber F, Chalabi M, van de Haar J, Fanchi LF et al (2018) Generation of tumor-Reactive T cells by Co-culture of peripheral blood lymphocytes and tumor organoids. Cell 174(6):1586\u2013. https:\/\/doi.org\/10.1016\/j.cell.2018.07.009PubMed PMID: WOS:000443841000024","journal-title":"Cell"},{"issue":"7798","key":"6314_CR15","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1038\/s41586-020-2056-8","volume":"579","author":"TD Wu","year":"2020","unstructured":"Wu TD, Madireddi S, de Almeida PE, Banchereau R, Chen YJJ, Chitre AS et al (2020) Peripheral T cell expansion predicts tumour infiltration and clinical response. Nature 579(7798):274\u2013. https:\/\/doi.org\/10.1038\/s41586-020-2056-8PubMed PMID: WOS:000516702000003","journal-title":"Nature"},{"key":"6314_CR16","doi-asserted-by":"publisher","unstructured":"Zhang G, Liu AQ, Yang YJ, Xia Y, Li WT, Liu YH et al (2022) Clinical predictive value of naive and memory T cells in advanced NSCLC. Front Immunol.;13. doi: ARTN 996348 https:\/\/doi.org\/10.3389\/fimmu.2022.996348. PubMed PMID: WOS:000891304800001","DOI":"10.3389\/fimmu.2022.996348"},{"issue":"3","key":"6314_CR17","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3892\/etm.2014.1489","volume":"7","author":"S Inoue","year":"2014","unstructured":"Inoue S, Setoyama Y, Odaka A (2014) Doxorubicin treatment induces tumor cell death followed by Immunomodulation in a murine neuroblastoma model. Exp Ther Med 7(3):703\u2013708. https:\/\/doi.org\/10.3892\/etm.2014.1489PubMed PMID: WOS:000332695500032","journal-title":"Exp Ther Med"},{"issue":"14","key":"6314_CR18","doi-asserted-by":"publisher","first-page":"4821","DOI":"10.1158\/0008-5472.Can-11-0950","volume":"71","author":"J Fucikova","year":"2011","unstructured":"Fucikova J, Kralikova P, Fialova A, Brtnicky T, Rob L, Bartunkova J et al (2011) Human tumor cells killed by anthracyclines induce a tumor-Specific immune response. Cancer Res 71(14):4821\u20134833. https:\/\/doi.org\/10.1158\/0008-5472.Can-11-0950PubMed PMID: WOS:000292763700010","journal-title":"Cancer Res"},{"issue":"3","key":"6314_CR19","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s00277-020-04389-5","volume":"100","author":"QQ Zhu","year":"2021","unstructured":"Zhu QQ, Deng XQ, Yao WQ, Chen ZH, Ye YX, Gao LM et al (2021) Novel tumour-infiltrating lymphocyte-related risk stratification based by flow cytometry for patients with de Novo angioimmunoblastic T cell lymphoma. Ann Hematol 100(3):715\u2013723 PubMed PMID: WOS:000604205800001","journal-title":"Ann Hematol"},{"key":"6314_CR20","doi-asserted-by":"publisher","unstructured":"Zhu QQ, Yang YM, Deng XQ, Chao NN, Chen ZH, Ye YX et al (2023) High CD8 tumor-infiltrating lymphocytes indicate severe exhaustion and poor prognosis in angioimmunoblastic T-cell lymphoma. Front Immunol.;14. doi: ARTN 1228004 https:\/\/doi.org\/10.3389\/fimmu.2023.1228004. PubMed PMID: WOS:001074854600001","DOI":"10.3389\/fimmu.2023.1228004"},{"issue":"1","key":"6314_CR21","doi-asserted-by":"publisher","first-page":"368","DOI":"10.4143\/crt.2018.010","volume":"51","author":"YP Zhang","year":"2019","unstructured":"Zhang YP, Zhang R, Zhu HY, Wang L, Wu YJ, Ling JH et al (2019) Circulating low absolute CD4\u2009+\u2009T cell counts May predict poor prognosis in extranodal NK\/T-Cell lymphoma patients treating with Pegaspargase-Based chemotherapy. Cancer Res Treat 51(1):368\u2013377. https:\/\/doi.org\/10.4143\/crt.2018.010PubMed PMID: WOS:000455439600035","journal-title":"Cancer Res Treat"},{"issue":"1","key":"6314_CR22","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1002\/hon.2080","volume":"32","author":"A Singh","year":"2014","unstructured":"Singh A, Schabath R, Ratei R, Stroux A, Klemke CD, Nebe T et al (2014) Peripheral blood sCD3-CD4\u2009+\u2009T cells: a useful diagnostic tool in angioimmunoblastic T cell lymphoma. Hematol Oncol 32(1):16\u201321 PubMed PMID: WOS:000333010200003","journal-title":"Hematol Oncol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06314-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-025-06314-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-025-06314-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T10:10:49Z","timestamp":1745575849000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-025-06314-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["6314"],"URL":"https:\/\/doi.org\/10.1007\/s00277-025-06314-0","relation":{},"ISSN":["0939-5555","1432-0584"],"issn-type":[{"type":"print","value":"0939-5555"},{"type":"electronic","value":"1432-0584"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"12 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study protocol received approval from the Ethics Committee of Peking University Cancer Hospital & Institute, with written informed consent obtained from all participants. All procedures adhered to the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}